WallStSmart

Kenvue Inc. (KVUE)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 5212% more annual revenue ($15.41B vs $290.05M). KVUE leads profitability with a 10.8% profit margin vs -9.8%. SKIN appears more attractively valued with a PEG of 0.93. KVUE earns a higher WallStSmart Score of 60/100 (C).

KVUE

Buy

60

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.22

SKIN

Hold

45

out of 100

Grade: D+

Growth: 2.7Profit: 2.5Value: 6.0Quality: 4.5
Piotroski: 6/9Altman Z: -0.38
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-86.5%)

Margin of Safety

-86.5%

Fair Value

$9.94

Current Price

$17.78

$7.84 premium

UndervaluedFair: $9.94Overvalued

Intrinsic value data unavailable for SKIN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

SKIN2 strengths · Avg: 8.0/10
PEG RatioValuation
0.938/10

Growing faster than its price suggests

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

SKIN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$88.50M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
5.0%3/10

Operating margin of 5.0%

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : SKIN

The strongest argument for SKIN centers on PEG Ratio, Price/Book. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Operating Margin. Debt-to-equity of 6.60 is elevated, increasing financial risk.

Key Dynamics to Monitor

KVUE profiles as a value stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 0.99 — expect wider price swings.

KVUE is growing revenue faster at 3.0% — sustainability is the question.

KVUE generates stronger free cash flow (549M), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (60/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?